Skip to content
Search

Latest Stories

Vaccines saved nearly 12,000 lives in England

An analysis by Public Health England (PHE) on Friday revealed that the rollout of Covid-19 vaccines in England has prevented nearly 12,000 deaths and more than 30,000 hospitalisations in older people.

Britain has given two-thirds of its adult population at least one shot of Covid-19 vaccine, helping prime minister Boris Johnson in his efforts to reopen the economy by the summer.


Up until the end of April, the Covid-19 vaccination programme prevented 11,700 deaths in people aged 60 or over in England, PHE said. An estimated 33,000 hospitalisations of people aged 65 and above had been avoided in the same period.

The PHE figures did not cover Scotland, Wales or Northern Ireland, whose devolved governments make their own policy on combatting the pandemic.

PHE also said the estimate accounted only for the direct effects of vaccines, and “clear and increasing” evidence that vaccines help reduce transmission meant the numbers of deaths and hospitalisations prevented by vaccines was likely higher.

“The vaccine has already saved so many lives and we can now see the huge impact it has had on preventing people becoming seriously ill and therefore also protecting our hospitals,” said Mary Ramsay, head of immunisation at PHE.

There have been 127,640 deaths in Britain from Covid-19 – the sixth highest death toll globally, according to a Reuters analysis.

More For You

Cargo plane unloading pharmaceuticals at US airport amid tariff concerns and stockpiling

Imports jumped in particular from Ireland, the top drug exporter to the US

Pic credit: iStock

Pharma imports to US surged in March as drugmakers look to avoid tariffs

Pharmaceutical imports to the US surged in March as drugmakers stocked up ahead of potential US tariffs on their products, which have historically been exempt from such fees.

Total imports of pharmaceutical products exceeded $50 billion in the month - the equivalent of 20 per cent of all pharmaceutical imports in 2024, according to data from a U.S. Commerce Department report on Tuesday.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less